FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileCDT Equity Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
CDTTW
CDT Equity Inc. Stock AnalysisComprehensive stock analysis for CDT Equity Inc. (CDTTW) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisCDTTW
CDTTW
CDT Equity Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
CDTTW
  1. Home
  2. Stocks
  3. CDT Equity Inc.

CDT Equity Inc.

🇺🇸CDTTW•NASDAQ

CDT Equity Inc.

🇺🇸CDTTW•NASDAQ
Market cap
$11.41K

Your view on CDTTW

Mkt Cap
$11.41K
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About CDT Equity Inc.

Industry
Biotechnology
Sector
Healthcare
CEO
Andrew Regan
Headquarters
4581 Tamiami Trail North, Naples, FL, US
Industry
Biotechnology
Sector
Healthcare
CEO
Andrew Regan
Headquarters
4581 Tamiami Trail North, Naples, FL, US
Description

CDT Equity Inc., established in October 2021 by David Joszef Tapolczay and Freda C. Lewis-Hall, operates from its headquarters in Naples, Florida, with a core mission to advance the development and market introduction of clinical assets.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for CDT Equity Inc.. Starting points for CDT Equity Inc.: EPS $5903.62, beta 1.46 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for CDT Equity Inc.. Trailing twelve-month EPS for CDT Equity Inc. stands at $5903.62. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for CDT Equity Inc.. CDT Equity Inc. has reported as a listed company since 2022. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold CDTTW20 companies
Compare CDTTW with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustryMkt cap
AKTXAkari Therapeutics, PlcHealthcareBiotechnology$16.5M
BDRXBiodexa Pharmaceuticals PlcHealthcareBiotechnology$174,870
DRMADermata Therapeutics, Inc.HealthcareBiotechnology$2.5M
MSPRMSP Recovery, Inc.HealthcareMedical - Healthcare Information Services$1,377
PBMPsyence Biomedical Ltd.HealthcareBiotechnology$56,486
PPBTPurple Biotech Ltd.HealthcareBiotechnology$210,578
REVBRevelation Biosciences, Inc.HealthcareBiotechnology$2.0M
SLXNWSilexion Therapeutics Ltd.HealthcareBiotechnology$36,808
More Biotechnology companies
TickerTypeCompanySectorExchangeMkt cap
ASPHFAscentage Pharma Group InternationalHealthcareOTC$3.2B
ATAIAtai Life Sciences N.V.HealthcareNASDAQ$2.7B
ATGGFActinogen Medical LimitedHealthcareOTC$107.7M
ATH.AXAlterity Therapeutics LimitedHealthcareASX—
ATHEAlterity Therapeutics LimitedHealthcareNASDAQ$25.8M
ATNMActinium Pharmaceuticals, Inc.HealthcareAMEX$33.0M
ATOSAtossa Therapeutics, Inc.HealthcareNASDAQ$15.9M
ATRAAtara Biotherapeutics, Inc.HealthcareNASDAQ$64.5M
ATRXAdhera Therapeutics, Inc.HealthcareOTC$722
ATX.AXAmplia Therapeutics LimitedHealthcareASX—
ATXIAvenue Therapeutics, Inc.HealthcareOTC$2.5M
ATYRaTyr Pharma, Inc.HealthcareNASDAQ$9.4M
Open Comparable Analysis
Ownership & News

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by CDT Equity Inc. executives and directors. Shares of CDT Equity Inc. have traded between $0.01 and $0.01 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for CDT Equity Inc.. Coverage tracks CDT Equity Inc. within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of CDT Equity Inc.

CDTTW AnalysisFair
Past
1
Growth
2
Health
5
Profit
5
Value
1